Icon

CUVRIOR (nda215760)- (300MG)

TRIENTINE TETRAHYDROCHLORIDE ORPHALAN
300MG
Yes Yes
2039-May-03 Expired
None 2025-Apr-28
None No
CUVRIOR is a copper chelator indicated for the treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to penicillamine.
0 0 0
Total Other Developers 2
Drugs with Suitability No
300MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.